Track topics on Twitter Track topics that are important to you
AUSTIN, Texas, July 21, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and New Generation Consumer Group Inc. (OTC PINK:NGCG) announced today that a new audio interview with New Generation Consumer Group Inc. is now available. The interview can be heard at http://smallcapvoice.com/blog/7-14-15-smallcapvoice-interview-with-new-generation-consumer-group-inc-ngcg/
NGCG's COO, Phil Longoria, called into SmallCapVoice.com to provide the listening audience with a comprehensive overview of the Company's history, the highlights for the Company in 2015, as well as his own candid insights into the goals for the Company for the remainder of 2015.
"Our Company has come a long way in a short amount of time and we know that our investors want to hear from us about our future plans," stated Longoria. "We appreciate the opportunity to share our story with our shareholders and the SmallCapVoice.com listening audience."
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About New Generation Consumer Group, Inc.
New Generation Consumer Group, Inc. (NGCG) is a marketing and media company that currently operates through four separate divisions: Mucho Macho, VIP Spirits, Monster Marketing, and our Snack Division. Mucho Macho features Mucho Macho Michelada Mix as its featured product. Our VIP Spirits Division will feature Excuse as our premium liqueur brand. Our initial alcohol product will be a Top Shelf Liqueur infused Premium Imported Vodka in a variety of different flavors, followed by Excuse Whiskey. Monster Marketing provides graphic design, web development, and brand management, in addition to other various services to its clients to help them gain more customers, increase sales, aid in selling products and services and or to create brand awareness. Our snack division brings consumers spicy and intense flavoring of noticeable quality for today's particular tastes. Additional information may be found at http://www.newgencg.com, https://www.facebook.com/muchomachomichelada, or https://twitter.com/MuchoMachoMiche.
Safe Harbor and Forward-Looking Statements
This press release contains forward-looking statements. Words such as "expects," "intends," "believes," and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
CONTACT: Corporate Relations and Retail Inquiries Phil Longoria ir@NewGenCG.com For SmallCapVoice.com Stuart T. Smith 512-267-2430 email@example.comNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...